Management of lower-risk myelodysplastic syndromes without del5q: current approach and future trends

M S Holm, M Karimi, L Brandefors, H Garelius, M Grövdal, I Högh-Dufva, K Grønbæk, M Jansson, C Marcher, L Nilsson, A O Kittang, A Porwit, L Saft, L Möllgård, E Hellström-Lindberg, M Tobiasson, I Dybedahl, Limited clinical efficacy of azacitidine in transfusion-dependent, growth factor-resistant, low- and Int-1-risk MDS: Results from the nordic NMDSG08A phase II trial Blood Cancer Journal. ,vol. 4, ,(2014) , 10.1038/BCJ.2014.8

Matthias Bartenstein, H. Joachim Deeg, Hematopoietic stem cell transplantation for MDS. Hematology-oncology Clinics of North America. ,vol. 24, pp. 407- 422 ,(2010) , 10.1016/J.HOC.2010.02.003

W.R. Sperr, F. Wimazal, M. Kundi, C. Baumgartner, T. Nösslinger, A. Makrai, R. Stauder, O. Krieger, M. Pfeilstöcker, P. Valent, Comorbidity as prognostic variable in MDS: comparative evaluation of the HCT-CI and CCI in a core dataset of 419 patients of the Austrian MDS Study Group Annals of Oncology. ,vol. 21, pp. 114- 119 ,(2010) , 10.1093/ANNONC/MDP258

Susan D. Ross, I. Elaine Allen, Corey A. Probst, Brian Sercus, Sheila M. Crean, Gayatri Ranganathan, Efficacy and safety of erythropoiesis-stimulating proteins in myelodysplastic syndrome: a systematic review and meta-analysis. Oncologist. ,vol. 12, pp. 1264- 1273 ,(2007) , 10.1634/THEONCOLOGIST.12-10-1264

David Valcárcel, Guillermo Sanz, Margarita Ortega, Benet Nomdedeu, Elisa Luño, María Diez-Campelo, María Teresa Ardanaz, Carmen Pedro, Julía Montoro, Rosa Collado, Rafa Andreu, Victor Marco, María Teresa Cedena, Raquel de Paz, Mar Tormo, Blanca Xicoy, Fernando Ramos, Joan Bargay, Bernardo Gonzalez, Salut Brunet, Juan Antonio Muñoz, Valle Gomez, Alicia Bailén, Joaquin Sanchez, Brayan Merchán, Consuelo del Cañizo, Teresa Vallespí, Use of newer prognostic indices for patients with myelodysplastic syndromes in the low and intermediate-1 risk categories: a population-based study The Lancet Haematology. ,vol. 2, ,(2015) , 10.1016/S2352-3026(15)00067-8

Matthew J. Walter, Dong Shen, Li Ding, Jin Shao, Daniel C. Koboldt, Ken Chen, David E. Larson, Michael D. McLellan, David Dooling, Rachel Abbott, Robert Fulton, Vincent Magrini, Heather Schmidt, Joelle Kalicki-Veizer, Michelle O'Laughlin, Xian Fan, Marcus Grillot, Sarah Witowski, Sharon Heath, John L. Frater, William Eades, Michael Tomasson, Peter Westervelt, John F. DiPersio, Daniel C. Link, Elaine R. Mardis, Timothy J. Ley, Richard K. Wilson, Timothy A. Graubert, Clonal Architecture of Secondary Acute Myeloid Leukemia The New England Journal of Medicine. ,vol. 366, pp. 1090- 1098 ,(2012) , 10.1056/NEJMOA1106968

Aristoteles Giagounidis, Ghulam J. Mufti, Pierre Fenaux, Ulrich Germing, Alan List, Kyle J. MacBeth, Lenalidomide as a disease-modifying agent in patients with del(5q) myelodysplastic syndromes: linking mechanism of action to clinical outcomes. Annals of Hematology. ,vol. 93, pp. 1- 11 ,(2014) , 10.1007/S00277-013-1863-5

Nicole Casadevall, Pierre Durieux, Stéphanie Dubois, François Hemery, Eric Lepage, Marie-Catherine Quarré, Gandhi Damaj, Stéphane Giraudier, Agnes Guerci, Guy Laurent, Hervé Dombret, Christine Chomienne, Vincent Ribrag, Aspasia Stamatoullas, Jean-Pierre Marie, Anne Vekhoff, Frédéric Maloisel, Robert Navarro, François Dreyfus, Pierre Fenaux, Groupe Francais des Myelodysplasies, Health, economic, and quality-of-life effects of erythropoietin and granulocyte colony-stimulating factor for the treatment of myelodysplastic syndromes: a randomized, controlled trial. Blood. ,vol. 104, pp. 321- 327 ,(2004) , 10.1182/BLOOD-2003-07-2252

M Stadler, U Germing, K-O Kliche, K M Josten, R Kuse, W-K Hofmann, H Schrezenmeier, J Novotny, O Anders, H Eimermacher, W Verbeek, H-H Kreipe, H Heimpel, C Aul, A Ganser, A prospective, randomised, phase II study of horse antithymocyte globulin vs rabbit antithymocyte globulin as immune-modulating therapy in patients with low-risk myelodysplastic syndromes Leukemia. ,vol. 18, pp. 460- 465 ,(2004) , 10.1038/SJ.LEU.2403239

Amer M. Zeidan, Mikkael A. Sekeres, Xiao-Feng Wang, Najla Al Ali, Guillermo Garcia-Manero, David P. Steensma, Gail Roboz, John Barnard, Eric Padron, Amy DeZern, Jaroslaw P. Maciejewski, Alan F. List, Rami S. Komrokji, , Comparing the prognostic value of risk stratifying models for patients with lower-risk myelodysplastic syndromes: Is one model better? American Journal of Hematology. ,vol. 90, pp. 1036- 1040 ,(2015) , 10.1002/AJH.24173